Cerebrolysin® reduces microglial activation in vivo and in vitro: a potential mechanism of neuroprotection
Neurotrophins, such as NGF, BDNF and NT-3 play a regulatory role on the function of microglial cells in vivo and in vitro, and the identification of new compounds with neurotrophic properties is becoming a new strategy for the prevention and/or treatment of neurodegenerative disorders. In this study we describe the use of two different models to demonstrate the ability of Cerebrolysin® to reduce microglial activation. The results of these in vitro and in vivo studies indicate that Cerebrolysin® might exert a neuroimmunotrophic activity reducing the extent of inflammation and accelerated neuronal death under pathological conditions such as those observed in neurodegenerative diseases.
KeywordsMicroglial Activation Kainic Acid Chronic Neuroinflammation Microglial Cell Culture Solid Phase Sandwich ELISA
Unable to display preview. Download preview PDF.
- Cacabelos R, Barquero M, García P, Álvarez XA, Varela de Seijas E (1991) Cerebrospinal fluid interleukin-lβ (IL-β) in Alzheimer’s disease and neurological disorders. Meth Find Exp Clin Pharmacol 13: 455 – 458Google Scholar
- Cacabelos R, Álvarez XA, Fernández-Novoa L, Franco-Maside A, Mangues R, Pellicer A, Nishimura T (1994) Brain interleukin-lβ in Alzheimer’s disease and vascular dementia. Meth Find Exp Clin Pharmacol 16: 141 – 151Google Scholar
- Lombardi VRM, Maneiro E, Cacabelos R (1998b) Apoptosis in neurodegenerative dis-eases: The neuroimmune network. Neurogeront Neurogeriat 2: 105 – 124Google Scholar
- Lorton D, Kocsis JM, King L, Madden K, Brunden KR (1996) beta-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes. J Neuroimmunol 67: 21–29Google Scholar
- Maneiro E, Lombardi VRM, Cacabelos R (1996) Rat cell cultures: experimental model to study neurodegenerative disorders and new pharmacological compounds. Meth Find Exp Clin Pharmacol 18: 615 – 645Google Scholar
- Maneiro E, Lombardi VRM, Cacabelos R (1998) Neuroimmune dysfunction in Alzheimer’s disease. Neurogeront Neurogeriat 2: 77 – 104Google Scholar
- Miguel-Hidalgo JJ, Cacabelos R (1998) β-Amyloid(l-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield. Acta Neuropathol 95: 455–465Google Scholar
- Windisch M, Gschanes A, Hutter-Paier B (1998) Neurotrophic activities and therapeutic experience with a brain derived peptide preparation. J Neural Transm [Suppl 53]: 289 – 298Google Scholar